BioXcel Therapeutics has offered a fast-action mouth-dissolving sublingual film formulation of dexmedetomidine.
Regulatory
Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.
Posted inMetabolism, New Drugs, Regulatory
Twymeeg: Completely New Drug for Treatment of Type 2 Diabetes Mellitus
Imeglimin is a universal anti-diabetic drug that incorporates the power of all existing glucose-lowering drugs.
Posted inMetabolism, New Drugs, Regulatory
Kerendia: New Drug for Diabetic Kidney Disease
Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Enjaymo: First Drug to Treat Cold Agglutinin Disease
Sutimlimab will reduce the need for red blood cell transfusion due to hemolysis.
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Tavneos: New Drug for ANCA-Associated Vasculitis
Avacopan is better than prednisone in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
Posted inNew Drugs, Oncology, Regulatory
Tivdak: New Drug for Cervical Cancer
Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Posted inNew Drugs, Regulatory
Vabysmo: New Drug for Wet Age-Related Macular Degeneration and Diabetic Macular Edema
Faricimab by Roche is a strong competitor to Eylea.
